Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis

Aberrant DNA methylation constitutes a well-established epigenetic marker for breast cancer. Changes in methylation early in cancer development may be clinically relevant for cancer detection and prognosis-based therapeutic decisions. In the present study, a combination of methyl-CpG immunoprecipita...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Faryna, Marta (VerfasserIn) , Konermann, Carolin (VerfasserIn) , Aulmann, Sebastian (VerfasserIn) , Lorenzo Bermejo, Justo (VerfasserIn) , Diederichs, Sven (VerfasserIn) , Rom, Joachim (VerfasserIn) , Weichenhan, Dieter (VerfasserIn) , Schirmacher, Peter (VerfasserIn) , Sinn, Peter (VerfasserIn) , Gerhäuser, Clarissa (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 28 August 2012
In: The FASEB journal
Year: 2012, Jahrgang: 26, Heft: 12, Pages: 4937-4950
ISSN:1530-6860
DOI:10.1096/fj.12-209502
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1096/fj.12-209502
Verlag, Volltext: https://www.fasebj.org/doi/abs/10.1096/fj.12-209502
Volltext
Verfasserangaben:Marta Faryna, Carolin Konermann, Sebastian Aulmann, Justo Lorenzo Bermejo, Markus Brugger, Sven Diederichs, Joachim Rom, Dieter Weichenhan, Rainer Claus, Michael Rehli, Peter Schirmacher, Hans-Peter Sinn, Christoph Plass, and Clarissa Gerhauser

MARC

LEADER 00000caa a2200000 c 4500
001 1581737041
003 DE-627
005 20220815025846.0
007 cr uuu---uuuuu
008 181010s2012 xx |||||o 00| ||eng c
024 7 |a 10.1096/fj.12-209502  |2 doi 
035 |a (DE-627)1581737041 
035 |a (DE-576)511737041 
035 |a (DE-599)BSZ511737041 
035 |a (OCoLC)1341019803 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Faryna, Marta  |e VerfasserIn  |0 (DE-588)1026176875  |0 (DE-627)726238171  |0 (DE-576)371450047  |4 aut 
245 1 0 |a Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis  |c Marta Faryna, Carolin Konermann, Sebastian Aulmann, Justo Lorenzo Bermejo, Markus Brugger, Sven Diederichs, Joachim Rom, Dieter Weichenhan, Rainer Claus, Michael Rehli, Peter Schirmacher, Hans-Peter Sinn, Christoph Plass, and Clarissa Gerhauser 
264 1 |c 28 August 2012 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.10.2018 
520 |a Aberrant DNA methylation constitutes a well-established epigenetic marker for breast cancer. Changes in methylation early in cancer development may be clinically relevant for cancer detection and prognosis-based therapeutic decisions. In the present study, a combination of methyl-CpG immunoprecipitation (MCIp) and human CpG island (CGI) arrays was applied to compare genome-wide DNA methylation profiles in 10 low-grade in situ and invasive breast cancers against 10 normal breast samples. In total, 214 CGIs were found to be hypermethylated in ≥6 of 10 tumors. Functional term enrichment analyses revealed an overrepresentation of homeobox genes and genes involved in transcription and regulation of transcription. Significant hypermethylation of 11 selected genes in tumor vs. normal tissue was validated in two independent sample sets (45 tumors and 11 controls, 43 tumors and 8 controls) using quantitative EpiTyper technology. In tumors, median methylation levels of BCAN, HOXD1, KCTD8, KLF11, NXPH1, POU4F1, SIM1, and TCF7L1 were ≥30% higher than in normal samples, representing potential biomarkers for tumor diagnosis. Using the 90th percentile of methylation levels in normal tissue as cutoff value, 62-92% of in situ samples (n=13), 72-97% of invasive samples from the first validation set (n=32), and 86-100% of invasive samples from the second validation set (n=43) were classified as hypermethylated. Hypermethylation of KLF11 and SIM1 might also be associated with increased risk of developing metastases. In summary, early methylation changes are frequent in the low-grade pathway of breast cancer and may be useful in the development of differential diagnostic and possibly also prognostic markers.—Faryna, M., Konermann, C., Aulmann, S., Bermejo, J. L., Brugger, M., Diederichs, S., Rom, J., Weichenhan, D., Claus, R., Rehli, M., Schirmacher, P., Sinn, H.-P., Plass, C., Gerhauser, C. Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis. 
700 1 |a Konermann, Carolin  |e VerfasserIn  |0 (DE-588)135902517  |0 (DE-627)572488262  |0 (DE-576)300709234  |4 aut 
700 1 |a Aulmann, Sebastian  |d 1973-  |e VerfasserIn  |0 (DE-588)124520197  |0 (DE-627)363393021  |0 (DE-576)294211519  |4 aut 
700 1 |a Lorenzo Bermejo, Justo  |d 1972-  |e VerfasserIn  |0 (DE-588)124754619  |0 (DE-627)706705572  |0 (DE-576)294483632  |4 aut 
700 1 |a Diederichs, Sven  |d 1976-  |e VerfasserIn  |0 (DE-588)129345695  |0 (DE-627)394259068  |0 (DE-576)297611461  |4 aut 
700 1 |a Rom, Joachim  |d 1975-  |e VerfasserIn  |0 (DE-588)130877018  |0 (DE-627)707590604  |0 (DE-576)298390833  |4 aut 
700 1 |a Weichenhan, Dieter  |e VerfasserIn  |0 (DE-588)1176216201  |0 (DE-627)1047370816  |0 (DE-576)516580582  |4 aut 
700 1 |a Schirmacher, Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1020440112  |0 (DE-627)691221197  |0 (DE-576)360427448  |4 aut 
700 1 |a Sinn, Peter  |d 1957-  |e VerfasserIn  |0 (DE-588)1022590944  |0 (DE-627)717004783  |0 (DE-576)365646342  |4 aut 
700 1 |a Gerhäuser, Clarissa  |d 1964-  |e VerfasserIn  |0 (DE-588)17267123X  |0 (DE-627)697604470  |0 (DE-576)133529568  |4 aut 
773 0 8 |i Enthalten in  |a Federation of American Societies for Experimental Biology  |t The FASEB journal  |d Hoboken, NJ : Wiley, 1987  |g 26(2012), 12, Seite 4937-4950  |h Online-Ressource  |w (DE-627)266889816  |w (DE-600)1468876-1  |w (DE-576)075962527  |x 1530-6860  |7 nnas 
773 1 8 |g volume:26  |g year:2012  |g number:12  |g pages:4937-4950  |g extent:14  |a Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis 
856 4 0 |u http://dx.doi.org/10.1096/fj.12-209502  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://www.fasebj.org/doi/abs/10.1096/fj.12-209502  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20181010 
993 |a Article 
994 |a 2012 
998 |g 17267123X  |a Gerhäuser, Clarissa  |m 17267123X:Gerhäuser, Clarissa  |d 140000  |e 140000PG17267123X  |k 0/140000/  |p 14  |y j 
998 |g 1176216201  |a Weichenhan, Dieter  |m 1176216201:Weichenhan, Dieter  |d 50000  |e 50000PW1176216201  |k 0/50000/  |p 8 
998 |g 1022590944  |a Sinn, Peter  |m 1022590944:Sinn, Peter  |d 910000  |d 912000  |e 910000PS1022590944  |e 912000PS1022590944  |k 0/910000/  |k 1/910000/912000/  |p 12 
998 |g 1020440112  |a Schirmacher, Peter  |m 1020440112:Schirmacher, Peter  |d 910000  |d 912000  |d 700000  |d 718000  |e 910000PS1020440112  |e 912000PS1020440112  |e 700000PS1020440112  |e 718000PS1020440112  |k 0/910000/  |k 1/910000/912000/  |k 0/700000/  |k 1/700000/718000/  |p 11 
998 |g 130877018  |a Rom, Joachim  |m 130877018:Rom, Joachim  |d 910000  |d 910400  |e 910000PR130877018  |e 910400PR130877018  |k 0/910000/  |k 1/910000/910400/  |p 7 
998 |g 129345695  |a Diederichs, Sven  |m 129345695:Diederichs, Sven  |d 910000  |d 912000  |d 700000  |d 718000  |e 910000PD129345695  |e 912000PD129345695  |e 700000PD129345695  |e 718000PD129345695  |k 0/910000/  |k 1/910000/912000/  |k 0/700000/  |k 1/700000/718000/  |p 6 
998 |g 124754619  |a Lorenzo Bermejo, Justo  |m 124754619:Lorenzo Bermejo, Justo  |d 910000  |d 999701  |e 910000PL124754619  |e 999701PL124754619  |k 0/910000/  |k 1/910000/999701/  |p 4 
998 |g 124520197  |a Aulmann, Sebastian  |m 124520197:Aulmann, Sebastian  |d 910000  |d 912000  |e 910000PA124520197  |e 912000PA124520197  |k 0/910000/  |k 1/910000/912000/ 
998 |g 135902517  |a Konermann, Carolin  |m 135902517:Konermann, Carolin  |d 910000  |d 912000  |e 910000PK135902517  |e 912000PK135902517  |k 0/910000/  |k 1/910000/912000/  |p 2 
999 |a KXP-PPN1581737041  |e 3028376091 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis","title_sort":"Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis"}],"relHost":[{"id":{"eki":["266889816"],"doi":["10.1096/(ISSN)1530-6860"],"zdb":["1468876-1"],"issn":["1530-6860"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"titleAlt":[{"title":"Journal"}],"origin":[{"dateIssuedKey":"1987","publisher":"Wiley ; FASEB","dateIssuedDisp":"1987-","publisherPlace":"Hoboken, NJ ; Bethesda, Md."}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"266889816","pubHistory":["1.1987 -"],"note":["Gesehen am 12.05.2020","Fortsetzung der Druck-Ausgabe"],"corporate":[{"role":"aut","display":"Federation of American Societies for Experimental Biology"}],"part":{"year":"2012","text":"26(2012), 12, Seite 4937-4950","extent":"14","pages":"4937-4950","volume":"26","issue":"12"},"language":["eng"],"disp":"Federation of American Societies for Experimental BiologyThe FASEB journal","title":[{"subtitle":"the journal of the Federation of American Societies for Experimental Biology","title":"The FASEB journal","title_sort":"FASEB journal"}]}],"note":["Gesehen am 10.10.2018"],"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"28 August 2012"}],"physDesc":[{"extent":"14 S."}],"recId":"1581737041","person":[{"display":"Faryna, Marta","family":"Faryna","role":"aut","given":"Marta"},{"role":"aut","given":"Carolin","family":"Konermann","display":"Konermann, Carolin"},{"family":"Aulmann","display":"Aulmann, Sebastian","given":"Sebastian","role":"aut"},{"given":"Justo","role":"aut","display":"Lorenzo Bermejo, Justo","family":"Lorenzo Bermejo"},{"family":"Diederichs","display":"Diederichs, Sven","given":"Sven","role":"aut"},{"role":"aut","given":"Joachim","family":"Rom","display":"Rom, Joachim"},{"given":"Dieter","role":"aut","family":"Weichenhan","display":"Weichenhan, Dieter"},{"given":"Peter","role":"aut","display":"Schirmacher, Peter","family":"Schirmacher"},{"given":"Peter","role":"aut","display":"Sinn, Peter","family":"Sinn"},{"role":"aut","given":"Clarissa","display":"Gerhäuser, Clarissa","family":"Gerhäuser"}],"id":{"eki":["1581737041"],"doi":["10.1096/fj.12-209502"]},"name":{"displayForm":["Marta Faryna, Carolin Konermann, Sebastian Aulmann, Justo Lorenzo Bermejo, Markus Brugger, Sven Diederichs, Joachim Rom, Dieter Weichenhan, Rainer Claus, Michael Rehli, Peter Schirmacher, Hans-Peter Sinn, Christoph Plass, and Clarissa Gerhauser"]},"type":{"bibl":"article-journal","media":"Online-Ressource"}} 
SRT |a FARYNAMARTGENOMEWIDE2820